Clinical Trials on COVID-2019 Pneumonia

Total 10227 results

AudibleHealth AI, Inc.
Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... and other collaborators

Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

Coronavirus Disease 2019 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19 | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease

United States
Akesobio Australia Pty Ltd

Completed

A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

Coronavirus Disease 2019 (COVID-19)

New Zealand
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Jilin University

Unknown

A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019

COVID-2019

China
AstraZeneca

Terminated

Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Germany
Tang-Du Hospital

Completed

Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

Coronavirus Disease 2019 (COVID-19)

China
Sinocelltech Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Coronavirus Disease 2019(COVID-19)

China
Janssen Vaccines & Prevention B.V.

Completed

A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive (HORIZON 2)

Coronavirus Disease-2019 (COVID-19) Prevention

Mexico, South Africa, Brazil, Argentina, India
CSL Behring

Completed

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

United States
Guangzhou Institute of Respiratory Disease
Tongji Hospital; Guangzhou Eighth People's Hospital; Guangzhou Cellgenes Biotechnology...

Unknown

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

China
CSL Behring

Terminated

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Coronavirus Disease 2019 (COVID-19)

Australia
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 COVID-19

United States
Prothione, LLC

Completed

A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Rwanda
CSL Behring

Withdrawn

CSL324 in COVID-19

Coronavirus Disease 2019 (COVID-19)
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

CoronaVirus Disease-2019 (COVID-19)

United States, Hungary, Israel, Netherlands, Puerto Rico
Materia Medica Holding

Active, not recruiting

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Coronavirus Disease 2019 (COVID-19)

Russian Federation
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Coronavirus Disease 2019 (COVID-19)

China
Tychan Pte Ltd.

Completed

Safety of TY027, a Treatment for COVID-19, in Humans

Coronavirus Disease-2019 (COVID-19)

Singapore
University of Lahore

Completed

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Corona Virus Disease 2019 (COVID-19)

Pakistan
Janssen Research & Development, LLC

Terminated

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (PREVENT-HD)

Coronavirus Disease 2019 (COVID-19)

United States
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Healthy Volunteer | Coronavirus Disease 2019 (COVID-19)

China
Yu Qin

Enrolling by invitation

Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

Corona Virus Disease 2019(COVID-19)

China
National Institute of Allergy and Infectious Diseases...

Completed

Collection of Anti-SARS-CoV-2 Immune Plasma (NIAID)

Coronavirus Disease 2019 (COVID-19)

United States
Beijing 302 Hospital
Maternal and Child Health Hospital of Hubei Province; Huoshenshan Hospital; VCANBIO... and other collaborators

Completed

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Corona Virus Disease 2019(COVID-19)

China
Henan Provincial People's Hospital

Unknown

Sequential Oxygen Therapy Strategy for Patients With COVID-19 (SOTSPC)

Coronavirus Disease-2019

China
Beijing Children's Hospital
The First Affiliated Hospital of Anhui Medical University; Shengjing Hospital; China-Japan Friendship Hospital and other collaborators

Unknown

Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children

2019-nCoV

China
China-Japan Friendship Hospital
Wuhan University; Wuhan Central Hospital; Wuhan lung Hospital; Ai You Foundation

Unknown

Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge

Pulmonary Rehabilitation | COVID-2019 Pneumonia

China
Fundacion Clinica Valle del Lili
Universidad Autonoma de Occidente

Completed

Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs (RedNeumon)

COVID-19 Pneumonia | COVID-19 (Coronavirus Disease 2019)

Colombia
Hospital Italiano de Buenos Aires
University of Buenos Aires; Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

Renal Dialysis | Coronavirus Disease 2019 Vaccines

Argentina
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia

Coronavirus Disease 2019 (COVID-19) Pneumonia

Turkey
Fuzhou General Hospital

Unknown

Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019

COVID-19 Pneumonia

China
Leading BioSciences, Inc

Withdrawn

LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia

COVID-19 | Covid19 | Coronavirus Disease 2019 | COVID-19 Pneumonia
Rabin Medical Center

Completed

Post-coronavirus Disease-2019 Fatigue

Covid19 | Post-COVID / Long-COVID

Israel
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Center for Outcomes...

Suspended

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

COVID-19 | Corona Virus Infection | SARS-CoV-2 | 2019-nCoV | 2019 Novel Coronavirus

United States
Humanigen, Inc.

Active, not recruiting

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Coronavirus Disease 2019 (COVID-19) Pneumonia

United States, Brazil
Hospital San Carlos, Madrid

Completed

Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency (COVIT-D)

Coronavirus Disease 2019 (COVID-19)

Spain
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 + (eChoVid)

Interstitial Pneumonia | 2019-nCoV (COVID-19)

France
Emmanouil D. Zacharakis

Recruiting

Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.

COVID-19 (Coronavirus Disease 2019)

Greece
Beijing Ditan Hospital

Completed

A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

Coronavirus Disease 2019(COVID-19)

China
Guangdong Raynovent Biotech Co., Ltd

Completed

The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants

COVID-19 (Coronavirus Disease 2019)

China
Tychan Pte Ltd.

Terminated

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Coronavirus Disease-2019 (COVID-19)

Singapore
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States
Cluster de Bioeconomia de Baja California, A.C
Bionag SAPI de CV; General Hospital Tijuana

Completed

Evaluation of Silver Nanoparticles for the Prevention of COVID-19 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Mexico
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

COVID-19 (Coronavirus Disease 2019)

United States
Volgograd State Medical University

Active, not recruiting

Thrombohemorrhagic Complications of COVID-19

COVID-19 (Coronavirus Disease 2019)

Russian Federation
AstraZeneca

Terminated

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (ENDURE)

Coronavirus Disease 2019 (COVID-19)

United States
Abu Dhabi Stem Cells Center

Completed

Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (SENTAD-COVID)

Coronavirus Disease 2019 (COVID-19)

United Arab Emirates

Clinical Trials on COVID-2019 Pneumonia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations